HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

 

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

 

In this episode of HOPA Now, Dr. Christy Harris addresses the main differentiating characteristics of sarcomas from all other cancers, including risk factors and prognosis, focusing mainly on soft tissue sarcomas. She reviews sarcoma identification and considerations, latest breakthroughs and treatments regarding GIST, and offers details for cytotoxic and other targeted treatments.

 

In this episode, you will learn:

 

Adult Sarcomas Fundamentals

• Differentiating characteristics of sarcomas from most other cancers
• An overview of the histology and two main categories of sarcomas
• Identification and percentages of various soft tissue sarcomas
• Risk factors and prognosis of soft tissue sarcomas
• Considerations regarding risk factors to remember when reviewing adult sarcomas
• The correlation between presentation and prognosis of sarcomas and their location
• Latest breakthroughs and treatments regarding GIST
• Details for cytotoxic and other targeted chemotherapy treatments

 

Mentioned in This Episode:

HOPA

 

Quotes:

 

“These characteristics described require us to approach this cancer differently than other neoplasms.” — Dr. Christy Harris

 

“Some sarcomas are technically considered to be benign tumors but have severe comorbidities so must be treated as a malignant tumor.” — Dr. Christy Harris

 

“Presentation of a sarcoma as well as its prognosis is heavily dependent on where it is located in the body.” — Dr. Christy Harris